Dyne Therapeutics, Inc. (DYN) vs Nurix Therapeutics, Inc. (NRIX)
- Dyne Therapeutics, Inc. DYN 14.25 −6.80%
- Nurix Therapeutics, Inc. NRIX 24.42 −2.12%
Dyne Therapeutics, Inc. and Nurix Therapeutics, Inc. are both Biotechnology companies. Dyne Therapeutics, Inc. and Nurix Therapeutics, Inc. are of similar size ($2.9B and $2.7B). Dyne Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Nurix Therapeutics, Inc. trades at 9.7×. Nurix Therapeutics, Inc. has the higher net margin (42.0% vs 0.00%) and the higher return on invested capital (0.00% vs −1,956.3%). Across the 14 metrics below, Nurix Therapeutics, Inc. leads on 11 and Dyne Therapeutics, Inc. on 3.
Valuation
Profitability
| Metric | DYN | NRIX | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | 41.27% | 0.00% |
| Net margin | 0.00% | 42.01% | 0.00% |
| Free cash flow margin | 0.00% | 52.68% | 0.00% |
| Return on equity | (81.57%) | 43.99% | (56.36%) |
| Return on assets | (60.29%) | 34.33% | (48.04%) |
| Return on invested capital | (1,956.27%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack